Impact of Metformin Therapy on Vitamin B12 Levels in Patients With Type 2 Diabetes Mellitus
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1867017849172656128 |
|---|---|
| author | Sahar H. Mahmoud Fatma R. Elfargani Nagwa Mohamed Fiaza A. Alhamdi |
| author_facet | Sahar H. Mahmoud Fatma R. Elfargani Nagwa Mohamed Fiaza A. Alhamdi Sahar H. Mahmoud Fatma R. Elfargani Nagwa Mohamed Fiaza A. Alhamdi |
| collection | Wiley Open Access |
| contents | Impact of Metformin Therapy on Vitamin B12 Levels in Patients With Type 2 Diabetes Mellitus Sahar H. Mahmoud Fatma R. Elfargani Nagwa Mohamed Fiaza A. Alhamdi Endocrinology, Diabetes & Metabolism ABSTRACTIntroductionDiabetes mellitus (DM) is a serious health condition affecting people worldwide with a high prevalence rate. DM is classified according to its aetiology into type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM); several risk factors contribute to the development of T2DM, such as age, genetic predisposition and obesity. Metformin is a proven drug of choice, and it is used as a first‐line treatment for patients with T2DM to improve their glycaemic levels. Vitamin B12 is an important water‐soluble vitamin, and its deficiency can lead to megaloblastic anaemia.Material and MethodsA Cross‐sectional retrospective study was conducted on patients with T2DM in a Sedi Hussein diabetic polyclinic in Benghazi, Libya. The total sample was 381 patients: T1DM 15 (n), and T2DM 366 (n). T1DM was excluded from our results. Patients with T2DM were divided into two groups: the control group (not on metformin) consisted of 71 patients, and the group that received metformin (M group) consisted of 295 patients.Aims of the StudyTo assess serum vitamin B12 levels in patients with T2DM and evaluate the prevalence of vitamin B12 deficiency among those receiving metformin treatment.ResultsThe M group significantly decreased vitamin B12 serum levels by 443.56 mg/mL versus the control group of 541.33 pg/mL (p = 0.003). The prevalence of patients with vitamin B12 deficiency under the metformin treatment was 23.84%. There was no significant difference in correlation between serum vitamin B12 levels and both doses of metformin and the duration of diabetes mellitus.ConclusionVitamin B12 was significantly decreased in patients with T2DM receiving metformin. 10.1002/edm2.70049 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1002/edm2.70049 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_edm2_70049 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2025 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Impact of Metformin Therapy on Vitamin B12 Levels in Patients With Type 2 Diabetes Mellitus Sahar H. Mahmoud Fatma R. Elfargani Nagwa Mohamed Fiaza A. Alhamdi Endocrinology, Diabetes & Metabolism Impact of Metformin Therapy on Vitamin B12 Levels in Patients With Type 2 Diabetes Mellitus Sahar H. Mahmoud Fatma R. Elfargani Nagwa Mohamed Fiaza A. Alhamdi Endocrinology, Diabetes & Metabolism ABSTRACTIntroductionDiabetes mellitus (DM) is a serious health condition affecting people worldwide with a high prevalence rate. DM is classified according to its aetiology into type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM); several risk factors contribute to the development of T2DM, such as age, genetic predisposition and obesity. Metformin is a proven drug of choice, and it is used as a first‐line treatment for patients with T2DM to improve their glycaemic levels. Vitamin B12 is an important water‐soluble vitamin, and its deficiency can lead to megaloblastic anaemia.Material and MethodsA Cross‐sectional retrospective study was conducted on patients with T2DM in a Sedi Hussein diabetic polyclinic in Benghazi, Libya. The total sample was 381 patients: T1DM 15 (n), and T2DM 366 (n). T1DM was excluded from our results. Patients with T2DM were divided into two groups: the control group (not on metformin) consisted of 71 patients, and the group that received metformin (M group) consisted of 295 patients.Aims of the StudyTo assess serum vitamin B12 levels in patients with T2DM and evaluate the prevalence of vitamin B12 deficiency among those receiving metformin treatment.ResultsThe M group significantly decreased vitamin B12 serum levels by 443.56 mg/mL versus the control group of 541.33 pg/mL (p = 0.003). The prevalence of patients with vitamin B12 deficiency under the metformin treatment was 23.84%. There was no significant difference in correlation between serum vitamin B12 levels and both doses of metformin and the duration of diabetes mellitus.ConclusionVitamin B12 was significantly decreased in patients with T2DM receiving metformin. 10.1002/edm2.70049 http://creativecommons.org/licenses/by/4.0/ |
| title | Impact of Metformin Therapy on Vitamin B12 Levels in Patients With Type 2 Diabetes Mellitus |
| topic | Endocrinology, Diabetes & Metabolism |
| url | https://onlinelibrary.wiley.com/doi/10.1002/edm2.70049 |